Immunitybio is trading at $8.80, up +4.32%, on September 28, 2026, with no clear company-specific announcement identified to explain the gain.
- Recent coverage focused on expansion discussions in Turkey, but that earlier news does not establish the reason for this session’s rise.
- Broader markets are weaker amid rising oil prices, geopolitical concerns and higher Treasury yields; market-wide sentiment does not directly explain Immunitybio’s gain.
- No specific catalyst or reliable volume information was found for the live move.